HBHaytham Bouammali

Haytham Bouammali

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haytham Bouammali has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Unveiling the Therapeutic Potential of Flavones: A Review on Biological Activities and Mechanisms

    by Elmehdi Fraj, Mohammed Merzouki, Chaymae Bourhou, Haytham Bouammali, Krishna Kumar Yadav, Pankaj Kumar, Apurva Sharma, Mohammad Khalid, Fahad M. Aldosari, Allal Challioui, et al.

    Flavones, or 2‐phenylchromones, are a group of oxygenated heterocyclic compounds belonging to the family of flavonoids. Studying these secondary metabolites has regained interest due to their diverse pharmacological potential, including antioxidant, anticancer, antimicrobial, and anti‐inflammatory activities. Some secondary metabolites, such as flavopiridol and riviciclib, have progressed to clinical trials as cyclin‐dependent kinase (CDK) inhibitors. This review summarizes recent advances in the study of natural and synthetic flavones, with particular emphasis on their mechanisms of action and structure–activity relationships (SAR). Studies show that flavones have multiple functions, including regulation of oxidative stress, apoptosis, cell cycle arrest, microbial growth, and inflammation. Notably, the chemical modification of the flavone scaffold, particularly phenyl and chromone ring substitutions, affects the potency, selectivity, and therapeutic value and can therefore inform the rational design of drugs. The clinical advancement of flavopiridol and riviciclib demonstrates the potential for translating flavone‐based compounds into targeted CDK inhibitors. In this respect, we can consider flavones as a bioactive class of compounds with considerable potential for the development of new drugs. We expect more detailed mechanistic studies with SAR correlation to enable the production of new flavone compounds to broaden the use of these compounds to treat cancer, inflammation, and infectious diseases.


  • Open Access

    Design, Synthesis, and In Vitro Enzymatic Evaluation of Novel Flavone Derivatives as Dual COX-2/5-LOX Inhibitors Supported by Molecular Docking and ADMET Analysis

    by Elmehdi Fraj, Amine Elbouzidi, Haytham Bouammali, Hanane Jaouani, Chaymae Bourhou, Mohamed Addi, Susu M. Zughaier, Allal Challioui, Rachid Touzani, Boufelja Bouammali

    The development of new anti-inflammatory agents with improved safety and efficacy remains a major therapeutic challenge, particularly in light of the adverse effects associated with conventional nonsteroidal anti-inflammatory drugs. In this study, a series of new flavone derivatives were synthesized and evaluated for their inhibitory activities against Cyclooxygenase-1 (COX-1), Cyclooxygenase-2 (COX-2), and 5-Lipooxygenase (5-LOX) through combined in vitro and in silico approaches. Biological screening demonstrated that several derivatives exhibited moderate to strong inhibitory activity across the three enzymes, with IC50 values ranging from 35.67 ± 2.92 to 1137.44 ± 371.05µM. Among these, compounds 5a and 5b emerged as the most promising dual COX-2/5-LOX inhibitors, displaying potent activity toward both targets while maintaining limited COX-1 inhibition, as reflected by their favorable selectivity indices (SI = 2.09 and 5.21, respectively). Molecular docking studies supported the experimental findings, revealing favorable binding affinities of compounds 5a and 5b within the COX-2 active site (PDB: 1CX2), while the flavone–tetrazole hybrid 6b exhibited the highest binding affinity toward the 5-LOX active site (PDB: 6N2W), consistent with its notable inhibitory activity. In silico ADME and toxicity predictions further suggested that the selected derivatives (4a-b, 5a-b, and 6a-b) possess acceptable physiochemical properties, low predicted toxicity, and favorable drug-likeness. Overall, this study identifies flavone-based scaffolds as a promising early-stage lead for the development of dual COX-2/5-LOX inhibitors and provides a rational basis for the design of safer anti-inflammatory agents.


  • Dual COX/5-LOX inhibition by isorhamnetin-3-O-glucoside from Anthyllis cytisoides: An integrated chemical-enzymatic-computational study

    by Haytham Bouammali, Oussama Khibech, Elmehdi Fraj, Amine Elbouzidi, Ayoub Bekkouch, Chaymae Bourhou, Susu M. Zughaier, Mohammed Merzouki, Maryam Hassiba, Hanane Jaouani, et al.


  • Open Access

    Investigating lactic acid bacteria genus Lactococcus lactis properties: Antioxidant activity, antibiotic resistance, and antibacterial activity against multidrug-resistant bacteria Staphylococcus aureus

    by Nora Hamdaoui, Chaymae Benkirane, Haytham Bouaamali, Ali Azghar, Mohamed Mouncif, Adil Maleb, Belkheir Hammouti, Khalid Mashay Al-Anazi, Pankaj Kumar, Krishna Kumar Yadav, et al.


  • Open Access

    A Molecular Dynamics Examination into How Temperature Influences the Dissolution of Cellulose in an Aqueous Cuprammonium Hydroxide Solution

    by Lamiae Bourassi, Rania Abidi, Mohammed Merzouki, Meriem EL Mrani, Haytham I Bouammali, Boufelja Bouammali, Rachid Touzani, Larbi Elfarh, Allal Challioui, Sana BEN Moussa, et al.

    Molecular dynamics simulations were performed to examine the impact of temperature (ranging from 250K to 350K) on the structural behavior of cellulose chains when dissolved in an aqueous cuprammonium hydroxide Cuam solvent system. By monitoring the root mean square deviation (RMSD) and radius of gyration (Rg) values at each temperature, we found that the geometric deformation of the cellulose chains changed significantly at T=300K. In contrast, Rg and RMSD values remained stable at temperatures in the range of 250K, 270K and the range of 330K, 350K. Calculating the interaction energy between the solvent and cellulose chains revealed that temperature significantly influences the cellulose dissolution process in the Cuam solvent system and that T=300K is an efficient temperature for its dissolution. The number of intra- and interchain hydrogen bonds was also calculated as a function of temperature, and the analysis confirmed that there is no breakage of these bonds at temperatures below 300 K (i,e: 250K, 270K) and above 310 K (I,e, : 330K and 350K) either between two native chains or between a native chain and another derivative.


  • Open Access

    Rosemary as a Potential Source of Natural Antioxidants and Anticancer Agents: A Molecular Docking Study

    by Haytham Bouammali, Linda Zraibi, Imane Ziani, Mohammed Merzouki, Lamiae Bourassi, Elmehdi Fraj, Allal Challioui, Khalil Azzaoui, Rachid Sabbahi, Belkheir Hammouti, et al.

    Rosmarinus officinalis L. compounds, especially its main polyphenolic compounds, carnosic acid (CA) and rosmarinic acid (RA), influence various facets of cancer biology, making them valuable assets in the ongoing fight against cancer. These two secondary metabolites exhibit formidable antioxidant properties that are a pivotal contributor against the development of cancer. Their antitumor effect has been related to diverse mechanisms. In the case of CA, it has the capacity to induce cell death of cancer cells through the rise in ROS levels within the cells, the inhibition of protein kinase AKT, the activation of autophagy-related genes (ATG) and the disrupt mitochondrial membrane potential. Regarding RA, its antitumor actions encompass apoptosis induction through caspase activation, the inhibition of cell proliferation by interrupting cell cycle progression and epigenetic regulation, antioxidative stress-induced DNA damage, and interference with angiogenesis to curtail tumor growth. To understand the molecular interaction between rosemary compounds (CA and RA) and a protein that is involved in cancer and inflammation, S100A8, we have performed a series of molecular docking analyses using the available three-dimensional structures (PDBID: 1IRJ, 1MR8, and 4GGF). The ligands showed different binding intensities in the active sites with the protein target molecules, except for CA with the 1MR8 protein.